SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

JP Morgan Maintains Overweight on ChemoCentryx, Raises Price Target to $64

JP Morgan maintains ChemoCentryx (NASDAQ:CCXI) with a Overweight and raises the price target from $61 to $64.

Benzinga · 05/14/2020 13:19

JP Morgan maintains ChemoCentryx (NASDAQ:CCXI) with a Overweight and raises the price target from $61 to $64.